Strata Critical Medical, Inc. (SRTA) - Total Liabilities
Based on the latest financial reports, Strata Critical Medical, Inc. (SRTA) has total liabilities worth $41.89 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SRTA net assets growth trend to track the company's year-over-year net asset growth rate.
Strata Critical Medical, Inc. - Total Liabilities Trend (2019–2025)
This chart illustrates how Strata Critical Medical, Inc.'s total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Strata Critical Medical, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Strata Critical Medical, Inc. Competitors by Total Liabilities
The table below lists competitors of Strata Critical Medical, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Medistim ASA
OL:MEDI
|
Norway | Nkr151.23 Million |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $87.84K |
|
Wilson Bayly Holmes Ovcon Ltd
JSE:WBO
|
South Africa | ZAC9.51 Billion |
|
Delek Automotive Systems Ltd
TA:DLEA
|
Israel | ILA8.22 Billion |
|
GHCL Limited
NSE:GHCL
|
India | Rs7.48 Billion |
|
Heidelberger Druckmaschinen Aktiengesellschaft
F:HDD
|
Germany | €1.59 Billion |
|
Phat Dat Real Estate Development Corp
VN:PDR
|
Vietnam | ₫14.04 Trillion |
|
UPC Technology Corp
TW:1313
|
Taiwan | NT$25.50 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Strata Critical Medical, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SRTA market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.93 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Strata Critical Medical, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Strata Critical Medical, Inc. (2019–2025)
The table below shows the annual total liabilities of Strata Critical Medical, Inc. from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $46.40 Million | +33.58% |
| 2024-12-31 | $34.74 Million | -42.71% |
| 2023-12-31 | $60.64 Million | +19.99% |
| 2022-12-31 | $50.54 Million | +13.53% |
| 2021-12-31 | $44.51 Million | +570.88% |
| 2020-12-31 | $6.63 Million | -97.57% |
| 2019-12-31 | $272.69 Million | -- |
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including … Read more